- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$78.2 MnMarket Estimate, 2026
$85.73 MnMarket Forecast, 2034
$179 MnCAGR, 2026–2034
9.63%Asia Pacific Gamma Knife Market Size, Growth, Trends & Forecast (2026–2034)
The Asia Pacific Gamma Knife Market size was calculated to be USD 78.2 billion in 2025, is estimated to reach USD 85.73 billion in 2026, and is projected to expand to USD 179 billion by 2034, registering a compound annual growth rate (CAGR) of 9.63% during the forecast period from 2026 to 2034. Driven by a surging cancer burden, rising neurological cases, and increasing preference for non-invasive stereotactic radiosurgery across emerging markets, the market is witnessing exponential growth.
Key Executive Metrics (At-a-Glance)
- 2025 Base Valuation: USD 78.2 Billion
- 2026 Current Valuation: USD 85.73 Billion
- 2034 Forecast Valuation: USD 179 Billion
- Compound Annual Growth Rate (CAGR): 9.63% (2026–2034)
- Leading Country Market (Volume): Japan (holding the highest revenue share and volume in the region)
- Key Growth Hubs: China (fast-growing population and government approvals like CFDA), India (fastest-growing adopter of high-cost advanced technology)
Core Market Drivers
- Rising Cancer & Neurological Disorders: Escalating incidence of brain tumors, metastases, trigeminal neuralgia, and AVMs coupled with an aging demographic.
- Minimally Invasive Advantages: High safety profile, pin-point precision, minor surrounding tissue damage, and avoidance of traditional open surgeries.
Primary Market Restraints & Challenges
- High Capital & Treatment Costs: Expensive machinery implementation, strict regulatory standards, and lengthy licensing processes.
- Skilled Workforce Shortage: Scarcity of experienced neurosurgeons and specialized clinical professionals qualified to operate advanced Gamma Knife systems.
Market Segmentation: Largest and Fastest-Growing Segments
| Segment Category | Largest Segment | Fastest-Growing Segment |
|---|---|---|
| By Disease Indication | Brain Metastasis & Cancer | Trigeminal Neuralgia & AVM |
| By Country | Japan (Highest revenue share) | India & China (Rapid adoption & rising approvals) |
Major Industry Players Profiled
Key market participants shaping the Asia Pacific Gamma Knife landscape include Cyber Medical Corporation Ltd., ET Medical Group, American Shared Hospital Services, Masep Infini Asia Pacific, Inc., Hokai, Nordion Inc., Huiheng Medical Inc., Elekta AB, and Varian Medical Systems.
Asia Pacific Gamma Knife Market Size
The Asia Pacific gamma knife market was worth USD 78.2 billion in 2025. The global market is predicted to reach USD 85.73 billion in 2026 and USD 179 billion by 2034, growing at a CAGR of 9.63% from 2026 to 2034.
MARKET DRIVERS
Cancer Burden, Neurological Cases, and Minimally Invasive Demand Propel APAC Gamma Knife Market
Due to the increasing incidence of cancer and obesity and the aging population, the Asia Pacific Gamma Knife market is booming. Furthermore, the rise in the number of efforts made by various government organizations, the growing number of people with neurological disorders, and the enhanced features of Gamma Knife systems are propelling the market forward. Another key growth-boosting aspect is an increasing understanding of the technology involved in the operation and the appealing advantages it offers over open surgeries.
The market for gamma knife therapy in neurological treatment is likely to rise because of its advantages over traditional surgeries. Because it is a non-invasive procedure, it provides greater safety, minor injury to surrounding tissues, and pinpoint precision when treating target cells in the brain. The market is likely to drive by increased usage of these instruments in surgery centers due to the rising prevalence of neurological diseases and the growing desire for minimally invasive treatments. The Leksell Gamma Knife Icon, which was recently invented, is in high demand, and there is a greater need for this technology to be developed.
MARKET RESTRAINTS
High Costs, Licensing Delays, and Skilled Staff Shortage Limit APAC Gamma Knife Market Growth
The market's growth is hampered by strict regulatory standards, a lengthy licensing process for Gamma Knife systems, expensive implementation costs, and the scarcity of experienced professionals. Furthermore, the expense of treatment is highly significant. As a result, the majority of people cannot afford it. The tumor's severity also determines the expense of treatment.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Disease Indication, End User, and Country. |
| Various Analyses Covered | Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Countries Covered | India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and Rest of APAC |
| Market Leaders Profiled | Cyber Medical Corporation Ltd., ET Medical group and American Shared Hospital Services, Masep Infini Asia Pacific, Inc., Hokai, Nordion Inc, Huiheng Medical Inc, Elekta AB, Varian Medical Systems. |
COUNTRY LEVEL ANALYSIS
Geographically, Asia Pacific is expected to have the most significant CAGR during the forecast period because of the rising implementation of gamma knife surgical technology, also contributing to the expansion of this area in the gamma knife market is an increase in the number of patients with cancer and brain tumors, as well as improved healthcare technologies, particularly in emerging countries.
The China gamma knife market is witnessing significant growth due to expanding population, rising disposable income, an aging population, and rising awareness levels. As a result, the Asian market attracts more new entrants than the developed world.
The Japan gamma knife market has the highest revenue share in this region. Japan is the world's second-largest market in terms of volume. Increased disease and the growing use of gamma knife tools in surgery centers contribute to its domination.
The India gamma knife market is the fastest-growing region because of the increased use of high-cost, technologically advanced products. Due to the rising approval of gamma knife treatment systems, the Asia Pacific gamma knife market is likely to reach significantly throughout the forecast period.
For example, the China Food and Drug Administration (CFDA) approved Elekta's Leksell Gamma Knife Icon radiosurgery system in 2018, allowing healthcare practitioners to deliver this advanced technology to Chinese patients.
KEY MARKET PLAYERS
Top companies leading in the APAC Gamma Knife Market profiled in the report are Cyber Medical Corporation Ltd., ET Medical group and American Shared Hospital Services, Masep Infini Asia Pacific, Inc., Hokai, Nordion Inc, Huiheng Medical Inc, Elekta AB, Varian Medical Systems.
MARKET SEGMENTATION
This research report on the APAC Gamma Knife Market has been segmented and sub-segmented into the following categories.
By Disease Indication
- Brain Metastasis
- Cancer
- Trigeminal Neuralgia
- AVM
- Others
By Country
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of APAC